Ridge Bio Series B · $100M raised · (2023)

Ridge Bio is a biotechnology company focused on developing transformative gene therapies for patients with rare genetic diseases. Their platform aims to deliver precise and effective treatments by leveraging advanced gene editing and delivery technologies. The company is dedicated to addressing unmet medical needs and improving the lives of individuals affected by debilitating genetic conditions.